Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $0.6 | $0.8 | $1.1 | $1.1 | $1.3 | $1.1 | $1.0 | $1.1 | $1.2 | $1.6 | $1.8 | $1.3 | $2.0 | $2.0 | $2.8 | $3.3 | $4.7 | $8.9 | $7.9 | $8.0 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, West Pharmaceutical Services, Inc.'s last 12-month EPS is $6.8, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, West Pharmaceutical Services, Inc.'s EPS growth was (9.4%). The average annual EPS growth rates for West Pharmaceutical Services, Inc. have been 6.0% over the past three years, 17.0% over the past five years.
Over the last year, West Pharmaceutical Services, Inc.'s EPS growth was (9.4%), which is lower than industry growth of 3.3%. It indicates that West Pharmaceutical Services, Inc.'s EPS growth is Bad.